EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CVR

CVR

CHICAGO RIVET & MACHINE CO

Next earnings Aug 6, 2026

Sell
$10.28
▲ 0.00%
$10.28▼ -13.65%
over 1Y
L $8.67EODHDH $14.63
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-5.9%
1M+8.2%
3M+2.6%
YTD-26.4%
1Y-13.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C+
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)

Conservative balance sheet (liabilities/equity 0.24x); but unprofitable (net margin -3.9%).

Revenue (FY2025) $27.9M · FY2025

CHICAGO RIVET & MACHINE CO shows $27.9M in FY2025 revenue (+3.3% YoY), a -3.9% net margin, and -5.8% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$34.0M$33.6M$31.5M$27.0M$27.9M
Gross profit$6.47M$3.82M-$600K$1.06M$4.13M
Operating income$1.36M$3.56M-$5.84M-$5.16M-$1.20M
Net income$1.11M$2.87M-$4.40M-$5.62M-$1.08M
Diluted EPS—————
Net margin3.3%8.5%-14.0%-20.8%-3.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.21M
EV / EBITDA—
EV / Sales0.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-10.9%
FCF yield-15.7%

Quality & risk

ROIC (est.)-5.0%
Free cash flow-$1.56M
Total debt$0.00
Net cash$1.72M
Altman Z-Score4.14 safe
Piotroski F-Score4/8

Capital returns

Buyback yield—
Dividend yield (est.)1.2%
Shareholder yield1.2%
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-05-14
  2. 10-Q Quarterly report2026-05-08
  3. DEF 14A Proxy statement2026-04-03
  4. 10-K Annual report2026-03-24
  5. 10-Q Quarterly report2025-11-07
  6. 10-Q Quarterly report2025-08-08
  7. 8-K/A Amended 8-K2025-06-10
  8. 8-K Auditor change2025-06-02
  9. 8-K Shareholder vote2025-05-15

Recent filings

all on EDGAR ↗
4Period ending 2026-05-192026-05-21open ↗8-KPeriod ending 2026-05-122026-05-14open ↗SDFiling2026-05-14open ↗10-QPeriod ending 2026-03-312026-05-08open ↗DEF 14APeriod ending 2026-04-022026-04-03open ↗ARSPeriod ending 2025-12-312026-04-03open ↗10-KPeriod ending 2025-12-312026-03-24open ↗SCHEDULE 13DFiling2025-12-29open ↗4Period ending 2025-12-122025-12-16open ↗3Period ending 2025-12-112025-12-16open ↗SCHEDULE 13DFiling2025-12-12open ↗10-QPeriod ending 2025-09-302025-11-07open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueA+
GrowthB+
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$27.9M
+3.3% YoY
Net margin
-3.9%
ROE
-5.8%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$27.9M+3.3%
Net income-$1.08M+80.7%
Gross profit$4.13M+289.2%
Operating income-$1.20M+76.8%
Cash & equivalents$1.72M-10.6%
Total assets$23.3M-0.3%
Total liabilities$4.47M+33.9%
Stockholders' equity$18.8M-6.0%
Gross: 14.8%Op.: -4.3%L/E: 0.24x

Frequently asked

Is CHICAGO RIVET & MACHINE CO (CVR) a buy?
CVR currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.24x); but unprofitable (net margin -3.9%).
What is CHICAGO RIVET & MACHINE CO's quality score?
CVR scores 61.94117647058824/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000019871, latest 10-Q filed 2026-05-08) · EODHD · as of 6/22/2026, 11:38:38 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 0 sales

2026-05-19
Cooney Kent H
Director
Buy900.00 @ $9.85$8.87K
2025-12-12
MORRISSEY JOHN A
10% owner
Buy2.54K @ $14.36$36.4K
2014-03-17
Showel John L
Director
Sell3.00 @ $39.01$117.03
2013-03-18
Showel John L
Director
Sell4.00 @ $22.00$88.00
2010-11-30
Bourg Michael J
Director
Buy300.00 @ $17.75$5.33K
2009-11-30
Bourg Michael J
Director
Buy500.00 @ $14.47$7.24K
2009-11-30
Cooney Kent H
Director
Buy100.00 @ $14.50$1.45K
2004-05-12
Divane William T Jr
Director
Buy1.00K @ $29.20$29.2K
2004-05-12
Divane William T Jr
Director
Buy1.00K @ $29.25$29.3K

Dividends

Semi-annual
Yield (TTM)
0.9%
Annual / share
$0.09
Last ex-date
2026-03-06
Last amount
$0.03
ex 2026-03-06paid 2026-03-20$0.03
ex 2025-12-05paid 2025-12-19$0.03
ex 2025-09-05paid 2025-09-19$0.03
ex 2025-06-05paid 2025-06-20$0.03
ex 2025-03-05paid 2025-03-20$0.03
ex 2024-12-05paid 2024-12-20$0.03

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2012-11-07—▲ 0.00%8-K ↗
2012-08-15—▲ +0.26%8-K ↗
2012-05-08—▼ -0.74%8-K ↗
2012-03-30—▲ +1.90%8-K ↗
2011-11-14—▲ +1.24%8-K ↗
2011-08-10—▲ +0.31%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Chicago Rivet & Machine GAAP EPS of $1.12, revenue of $27.8MBearish
seekingalpha.com· 2026-03-25
Goldman: Oil market shock hits jet fuel, diesel harder; PBF, Par Pacific rated strong buy by Quant ratingsBearish
seekingalpha.com· 2026-03-17
Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focusBullish
seekingalpha.com· 2026-03-01
Cycle Pharmaceuticals acquiring Applied TherapeuticsBullish
seekingalpha.com· 2025-12-11
Chicago Rivet & Machine GAAP EPS of $0.07, revenue of $7.36M
seekingalpha.com· 2025-11-07
Oil and Gas Sector Strategies in Renewable Fuels Industry 2025-2030: Companies are Exploring Co-processing Pathways for Efficient, Low-cost Production IncreasesBullish
globenewswire.com· 2025-10-31

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score62 vs 67
Revenue growth3.3% vs 7.1%
Net margin-3.9% vs 10.5%
Return on equity-5.8% vs 12.3%
P/E— vs 25.5